In particular, the pioglitazone-associated reduction in miR-195-5p in circulating EVs and corresponding increased expression in AT appear to contribute to improved inflammatory milieu, glycemic control, and insulin sensitivity in subjects with T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.